Drugs / Immucothel
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 0 | NCT01489956 | Dec 2011 → Apr 2013 | autoimmune disease | National Institute of Allergy and Infectious Diseases (NIAID) | Terminated | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Immucothel | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01489956 ↗ |
| Modality | Protein / enzyme biologic | “Immucothel is a purified protein from a mollusk.” NCT01489956 ↗ |
| Route | Subcutaneous | “Immucothel can be given as a sub-q injection (under the skin) alone or with an adjuvant (a small amount of mineral oil).” NCT01489956 ↗ |